Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $87.9552W HIGH $124.44
Volume
46.74 K
Value Traded
23.79 M
Short % Float
5.09%
+1.71%Week
-1.91%1 Month
+6.07%3 Month
+23.45%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
2.15 B
EPS (TTM)
5.64
P/E Ratio
20.41
Ent. Value
2.11 B
Total Shares
18.68 M
Float Shares
18.13 M
Insiders
2.89%
Institutions
105.05%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
ADUS Catalyst Timeline
Dated clinical, regulatory and corporate events for Addus HomeCare Corp.
Catalyst Timeline
Dated clinical, regulatory & corporate events for Addus HomeCare Corp.
2Total events
0Upcoming
0Tier-1 (high impact)
2026 to 2026Coverage
Past FDA Catalysts and PDUFA Decisions
How ADUS actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
Addus HomeCare Corp. is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every ADUS program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Dixon Heather BrianneOfficer (President and Chief Operating) | Sell | -288 44,371 held | $93.77 | 06/22/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in ADUS
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| PROSIGHT MANAGEMENT, LP | 0.8 % (100 %) | 2.38 M | 24.05 K | 92.36% ( 11.54 K) |
ADUS Institutional Ownership Trends
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-16 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How ADUS ranks across every disease it competes in
Competitive Position is a premium feature
See how ADUS ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialADUS News
-ADUS
Oct 13, 2026▼ -0.3%today
Addus HomeCare Announces Third Quarter 2026 Earnings Release and Conference Call
Addus HomeCare Corporation has announced its earnings release for the third quarter of 2026, scheduled for November 3, 2026. The company will hold a conference call the following day to discuss the results. Key executives, including the CEO and CFO, will participate in the call.
Read more →-ADUS
Sep 14, 2026Addus HomeCare Announces a Definitive Agreement to Acquire Personal Care Division of AccentCare
Addus HomeCare Corporation has entered into a definitive agreement to acquire the personal care division of AccentCare for about $275 million. This acquisition specifically pertains to AccentCare's personal care operations outside of New York, excluding its hospice and home health services. This move is expected to strengthen Addus's position in the home care market.
Read more →-ADUS
Sep 8, 2026Addus HomeCare to Participate in the 2026 Jefferies Healthcare Services and Technology Conference
Addus HomeCare Corporation announced its participation in the 2026 Jefferies Healthcare Services and Technology Conference. Executives Brian Poff and Brad Bickham will represent the company during the event scheduled for September 14-15, 2026, in Nashville, Tennessee. A live broadcast and replay of their presentation will be available.
Read more →-ADUS
Aug 10, 2026Addus HomeCare Announces Departure of Heather Dixon and Return of Brad Bickham as Chief Operating Officer on an Interim Basis
Addus HomeCare Corporation has announced the departure of Heather Dixon, the President and Chief Operating Officer. In her place, Brad Bickham will return as the interim COO for one year. The company expressed gratitude for Dixon's contributions during her tenure.
Read more →-ADUS
Aug 3, 2026Addus HomeCare Announces Second Quarter 2026 Financial Results
Addus HomeCare Corporation reported its financial results for the second quarter of 2026, highlighting a significant increase in net service revenues and net income. The company achieved an 8.0% rise in revenues, totaling $377.4 million, and a net income of $27.6 million. Additionally, adjusted net income per diluted share saw a year-over-year increase of 16.1%. Adjusted EBITDA also experienced growth, reaching $49.2 million.
Read more →-ADUS
Jul 20, 2026Addus HomeCare Announces Second Quarter 2026 Earnings Release and Conference Call
Addus HomeCare Corporation announced its earnings release for the second quarter of 2026, set for August 3, 2026, after market close. The company will follow up with a conference call on August 4, 2026, at 9:00 a.m. Eastern Time, featuring key executives including the CEO and CFO. This event aims to provide insights into the company's performance.
Read more →-ADUS
May 5, 2026Addus HomeCare to Participate in Upcoming Investor Conferences in May
Addus HomeCare Corporation will participate in two significant investor conferences in May 2026. The BofA Securities 2026 Health Care Conference will take place on May 12, while the RBC Capital Markets 2026 Global Healthcare Conference is scheduled for May 19. Key executives will present at both events, highlighting the company's commitment to investor relations.
Read more →-ADUS
May 4, 2026Addus HomeCare Announces First Quarter 2026 Financial Results
Addus HomeCare has announced its financial results for the first quarter of 2026. The report provides insights into the company's performance during this period. However, specific details regarding revenue, expenses, or other financial metrics were not disclosed in the article.
Read more →-ADUS
Apr 20, 2026Addus HomeCare Announces First Quarter 2026 Earnings Release and Conference Call
Addus HomeCare has announced the date for its earnings release for the first quarter of 2026. The company will also host a conference call to discuss the results. Further details about the earnings and the call have not been provided in the article.
Read more →-ADUS
May 5, 2025ADDUS HOMECARE ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS
Addus HomeCare Corporation reported its first quarter 2025 financial results, showing a robust 20.3% increase in net service revenues to $337.7 million compared to the same quarter last year. Net income also rose to $21.2 million, driven by solid growth in its personal care segment, which accounted for 76.5% of revenues. The company successfully integrated Gentiva's personal care operations and experienced growth in its hospice segment as well. Overall, Addus is optimistic about future growth opportunities while maintaining a strong balance sheet.
Read more →-ADUS
Mar 11, 2025ADDUS HOMECARE ANNOUNCES PLANNED RETIREMENT OF BRAD BICKHAM
Addus HomeCare Corporation has announced the planned retirement of Brad Bickham, President and Chief Operating Officer, set for March 2026. Dirk Allison, the CEO, praised Bickham's leadership and the positive growth of the company during his tenure. The board has also extended Allison's contract for three additional years, ensuring continued stability in leadership. This transition is expected to support the ongoing execution of Addus's growth strategy while continuing to focus on patient care.
Read more →-ADUS
Feb 24, 2025ADDUS HOMECARE ANNOUNCES FOURTH QUARTER AND YEAR END 2024 FINANCIAL RESULTS
Addus HomeCare Corporation (ADUS) has reported its financial results for the fourth quarter and full year ending December 31, 2024. The company demonstrated a 7.5% increase in fourth quarter net service revenues, totaling $297.1 million, despite a marginal decline in net income. Notably, adjusted EBITDA grew by 10.3%, reflecting solid operational achievement. The strategic acquisition of Gentiva's personal care operations is anticipated to further enhance Addus's market presence and revenue capabilities into 2025.
Read more →-ADUS
Dec 2, 2024Brian W. Poff Dru Anderson Executive Vice President, FINN Partners Chief Financial Officer (615) 324-7346 Addus HomeCare Corporation dru.anderson@finnpartners.com (469) 535-8200 investorrelations@addus.com ADDU
Addus HomeCare Corporation has announced the completion of its acquisition of the personal care operations of Gentiva, enhancing its services to over 16,000 consumers daily across seven states. This strategic move adds approximately $280 million in annualized revenues and positions Addus as the leading provider of personal care services in Texas. The company has utilized funds from a recent public offering and its credit facility to finance the acquisition. Looking ahead, Addus is optimistic about integrating Gentiva's operations and continuing its growth strategy through further acquisitions.
Read more →-ADUS
Nov 4, 2024Brian W. Poff Dru Anderson Executive Vice President, Chief Financial Officer FINN Partners Addus HomeCare Corporation (615) 324-7346 (469) 535-8200 dru.anderson@finnpartners.com investorrelations@addus.com ADDU
Addus HomeCare Corporation reported strong financial results for Q3 2024, with net service revenues of $289.8 million, marking a 7.0% increase from Q3 2023. The company also achieved a net income of $20.2 million, alongside an 11.1% rise in adjusted EBITDA, driven by organic growth and recent acquisitions. Addus continues to leverage its expanding service capabilities while maintaining a solid cash position, further enhancing its growth prospects. Plans to acquire Gentiva's personal care operations aim to broaden market presence across new states.
Read more →About Addus HomeCare Corp.
Headquarters6303 COWBOYS WAY, FRISCO, TX, 75034
BIOPHARMAWATCH ELITE PLUS
Trade the next ADUS catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime